Data sheet
| Product Citations | Available now |
| Satisfaction | 100% |
| Request a quote | sales@novateinbio.com |
| Special price coverage | Available to countries in Asia, Africa, Australia, South America. Please contact us for best price. |
| Country of origin | The U.S. |
| Distributor | Worldwide |
More info
Citation:
Immunogenicity and safety of one versus two doses of tetravalent dengue vaccine in healthy children aged 2–17 years in Asia and Latin America: 18-month interim data from a phase 2, randomised, placebo-controlled study
Prof. XavierSáez-Llorens, MD et al. The Lancet. Infection Disease Volume 18, Issue 2, February 2018, Pages 162-170
Related products:
Feel free to contact sales@novateinbio.com for discount or bulk order pricing. Thank you!